These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 12840218
1. Molecular targets for green tea in prostate cancer prevention. Adhami VM, Ahmad N, Mukhtar H. J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218 [Abstract] [Full Text] [Related]
2. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Toxicol Appl Pharmacol; 2000 Apr 01; 164(1):82-90. PubMed ID: 10739747 [Abstract] [Full Text] [Related]
3. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H. J Cell Biochem; 2004 Feb 01; 91(2):232-42. PubMed ID: 14743383 [Abstract] [Full Text] [Related]
4. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Hussain T, Gupta S, Adhami VM, Mukhtar H. Int J Cancer; 2005 Feb 10; 113(4):660-9. PubMed ID: 15455372 [Abstract] [Full Text] [Related]
5. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Agarwal R. Biochem Pharmacol; 2000 Oct 15; 60(8):1051-9. PubMed ID: 11007941 [Abstract] [Full Text] [Related]
7. Prostate cancer chemoprevention by green tea. Gupta S, Ahmad N, Mukhtar H. Semin Urol Oncol; 1999 May 15; 17(2):70-6. PubMed ID: 10332919 [Abstract] [Full Text] [Related]
9. Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model. Sartor L, Pezzato E, Donà M, Dell'Aica I, Calabrese F, Morini M, Albini A, Garbisa S. Int J Cancer; 2004 Dec 10; 112(5):823-9. PubMed ID: 15386368 [Abstract] [Full Text] [Related]
10. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Johnson JJ, Bailey HH, Mukhtar H. Phytomedicine; 2010 Jan 10; 17(1):3-13. PubMed ID: 19959000 [Abstract] [Full Text] [Related]
12. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG. Shimizu M, Shirakami Y, Moriwaki H. Int J Mol Sci; 2008 Jun 10; 9(6):1034-1049. PubMed ID: 19325845 [Abstract] [Full Text] [Related]
18. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes. Deb G, Shankar E, Thakur VS, Ponsky LE, Bodner DR, Fu P, Gupta S. Mol Carcinog; 2019 Jul 10; 58(7):1194-1207. PubMed ID: 30854739 [Abstract] [Full Text] [Related]
19. Chemoprevention of oral cancer by green tea. Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, Drake L, Caughman GB, Schuster GS. Gen Dent; 2002 Jul 10; 50(2):140-6. PubMed ID: 12004708 [Abstract] [Full Text] [Related]
20. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. Oncogene; 2003 Jul 31; 22(31):4851-9. PubMed ID: 12894226 [Abstract] [Full Text] [Related] Page: [Next] [New Search]